Provided by Tiger Fintech (Singapore) Pte. Ltd.

Generation Bio Co.

0.4360
+0.070419.26%
Post-market: 0.4301-0.0059-1.35%19:52 EDT
Volume:1.70M
Turnover:684.26K
Market Cap:29.23M
PE:-0.40
High:0.4420
Open:0.3842
Low:0.3622
Close:0.3656
Loading ...

Generation Bio Co - Q4 Collaboration Revenue $4.19 Mln

THOMSON REUTERS
·
14 Mar

Generation Bio Reports Business Highlights and Fourth Quarter and Full Year 2024 Financial Results

GlobeNewswire
·
14 Mar

Generation Bio Co expected to post a loss of 30 cents a share - Earnings Preview

Reuters
·
28 Feb

Generation Bio to Present at the TD Cowen 45th Annual Health Care Conference

GlobeNewswire
·
24 Feb

Generation Bio participates in a conference call with JPMorgan

TIPRANKS
·
03 Feb

3 US Penny Stocks With Market Cap Under $70M

Simply Wall St.
·
24 Jan

Will Generation Bio (NASDAQ:GBIO) Spend Its Cash Wisely?

Simply Wall St.
·
16 Jan

Generation Bio Independent Director Acquires 131% More Stock

Simply Wall St.
·
16 Jan

Generation Bio Is Maintained at Buy by Needham

Dow Jones
·
08 Jan

Cautious Optimism for Generation Bio Amid Strategic Focus and Valuation Concerns

TIPRANKS
·
08 Jan

Strategic Shift and Focus on In Vivo siRNA Therapeutics: Generation Bio’s Streamlined Path Forward

TIPRANKS
·
08 Jan

BRIEF-Generation Bio Says Matthew Norkunas To Depart As CFO

Reuters
·
07 Jan

Generation Bio Appoints New CFO, Chief Scientific Officer

MT Newswires Live
·
07 Jan

Generation Bio Restructures Leadership and Focuses on siRNA

TIPRANKS
·
07 Jan

Generation Bio chief scientific officer Matthew Stanton to leave role

TIPRANKS
·
07 Jan

Generation Bio Co - Matthew Norkunas to Depart as CFO

THOMSON REUTERS
·
07 Jan

Generation Bio to Apply Ctlnp Delivery Technology to Develop Sirna Therapeutics for T Cell-Driven Autoimmune Diseases

THOMSON REUTERS
·
07 Jan